-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster III

Lymphoma: Chemotherapy, excluding Pre-Clinical Models Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Kara M. Kelly, MD1, Peter D. Cole, MD2, Lu Chen, PhD3*, Kenneth B Roberts, MD4*, David C. Hodgson, MD5*, Kathleen McCarten, MD6*, Steve Y Cho, MD7* and Cindy Schwartz, MD8

1Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York, NY
2Pediatrics, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
3Children's Oncology Group, Acadia, CA
4Radiation Oncology, Yale Cancer Center, New Haven, CT
5Radiation Medicine Programme, University of Toronto,Princess Margaret Cancer Centre, Toronto, ON, Canada
6Warren Alpert Medical School of Brown University, Providence, RI
7Nuclear Medicine Section of the Department of Radiology, University of Wisconsin Carbone Cancer Center, Madison, WI
8MD Anderson Cancer Center, Houston, TX

Ian W. Flinn, MD, PhD1,2, Mohamad Cherry, MD1,3, Michael Maris, MD1,4, Jeffrey V. Matous, MD1,4, Jesus G. Berdeja, MD1,2 and Manish R. Patel, MD1,5

1Sarah Cannon Research Institute, Nashville, TN
2Tennessee Oncology, PLLC, Nashville, TN
3Internal Medicine, Oklahoma University Health Sciences Center, Oklahoma City, OK
4Colorado Blood Cancer Institute, Denver, CO
5Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL

Paul A Hamlin Jr., MD1, Ian Flinn, MD2*, Nina wagner-Johnston, MD3*, Jan A Burger, MD, PhD4, Glenn Michelson, MD5*, Anjali Pandey, PhD5*, Matt Birrell5*, Greg P. Coffey, PhD5*, Janet M Leeds, PhD6*, John T. Curnutte, MD, PhD7 and Manish R. Patel, MD8

1Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Sarah Cannon Research Institute, Nashville, TN
3Washington University, St. Louis, MO
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Portola Pharmaceuticals Inc, South San Francisco, CA
6Portola Pharmaceuticals Inc, San Francisco, CA
7Portola Pharmaceuticals, Inc., South San Francisco, CA
8Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL

Georg Hess, MD1*, Ulrich Keller2*, Johannes Atta3*, Ulrich Bitz, MD4*, Christian Lerchenmueller5*, Wagner Karola6*, Christoph Medler7*, Christian Ruckes7*, Mathias Witzens-Harig, MD8*, Kai Huebel9*, Paul LaRosee10* and Martin H. Dreyling, MD, PhD11

1Universitatsmedizin Der Johannes Gutenberg Univers, Mainz, Germany
2III. Department of Internal Medicine, Hematology and Medical Oncology, Technische Universität München, Munich, Germany
3University of Frankfurt, Frankfurt, Germany
4HELIOS Klinikum Bad Saarow, Bad Saarow, Germany
5Onkologie, Muenster, Germany
6Charité, Gerlin, Germany
7IZKS, Mainz, Germany
8Dep. Med. V, University Hospital Heidelberg, Heidelberg, Germany
9University of Cologne, Cologne, Germany
10University of Jena, Jena, Germany
11Dept. of Medicine III, Univ. Hospital Grosshadern/LMU, Munich, Germany

Daniel O. Persky, MD1, Hongli Li, PhD2*, Lisa M. Rimsza, MD1, Paul M. Barr, MD3, Leslie L. Popplewell, MD4, Charles L. Bane, MD5*, Ann Von Gehr, MD6, Michael Leblanc, PhD2*, Richard I. Fisher, MD7*, Sonali M. Smith, MD8 and Jonathan W. Friedberg, MD, MMSc3

1University of Arizona, Tucson, AZ
2SWOG Statistical Center, Seattle, WA
3University of Rochester, Rochester, NY
4City of Hope, Duarte, CA
5Dayton NCORP/Dayton Physicians LLC, Dayton, OH
6Kaiser Permanente NCORP/Kaiser Permanente San Jose, San Jose, CA
7Fox Chase Cancer Center/Temple University School of Medicine, Philadelphia, PA
8University of Chicago, Chicago, IL

Sylvain Carras, MD1*, Benjamin Dubois2*, Delphine Senecal, MD3*, Philippe Quittet, MD4, jean-Philippe Vuillez, MD, PHD2*, Michel peoc'H, MD, PHD5*, jean-Philippe Jais6*, Thierry Lamy, MD PhD7 and Lysiane Molina, MD1*

1Haematology, Grenoble University Hospital, Grenoble, France
2Nuclear medicine department, Grenoble University Hospital, Grenoble, France
3Medipole de Savoie, Haematology, Chambéry, France
4Hôpital Lapeyronie - CHRU Montpellier, Montpellier, France
5Anatomopathology department, Grenoble University hospital, Grenoble, France
6Statistics, Paris Descartes University, Paris, France
7INSERM U917 - CHU de Rennes, Rennes, France

Chiara Rusconi, MD1*, Antonella Anastasia, MD2*, Annalisa Chiarenza3*, Luigi Marcheselli4*, Federica Cavallo5*, Sara Rattotti6*, Barbara Botto7*, Angela Ferrari8*, Manuela Zanni9, Marco Calabrese10*, Chiara Pagani, MD2*, Erika Meli, MD11*, Massimo Federico, MD12 and Giuseppe Rossi, MD13

1Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
2UO Ematologia, AO Spedali Civili, Brescia, Italy
3Division of Hematology, Ferrarotto Hospital, Catania, Italy
4Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Modena, Italy
5Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Torino, Italy
6Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
7SC Ematologia, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Torino, Italy
8Hematology Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy
9Hematology, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy
10Fondazione Italiana Linfomi ONLUS Secretary, Alessandria, Italy
11Division of Hematology, Niguarda Ca’ Granda Hospital, Milan, Italy
12Cattedra di Oncologia Medica, Università di Modena e Reggio Emilia, Modena, Italy
13Department of Hematology, Spedali Civili di Brescia, Brescia, Italy

Roberto Mario Santi1*, Manuela Ceccarelli2*, Gioacchino Catania3*, Chiara Monagheddu2*, Andrea Evangelista4*, Elisa Bernocco5*, Federico Monaco6*, Massimo Federico7, Umberto Vitolo, MD8, Sergio Cortelazzo9, Maria Giuseppina Cabras10*, Michele Spina11, Luca Baldini12*, Carola Boccomini13*, Annalisa Chiappella, MD14, Alessia Bari15*, Stefano Luminari, MD16*, Marco Calabrese17*, Alessandro Levis, MD18, Laura Contino19*, Giovannino Ciccone20* and Marco Ladetto21

1Hematology, Hospital, Alessandria, Italy
2SCDU Epidemiologia dei Tumori-CPO Piemonte, Torino, Italy
3Division of Hematology, Az Osp SS Antinio e Biagio e Cesare Arrigo, Alessandria, Italy
4Unit of Cancer Epidemiology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
5Division of Haematology - SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandrio, Italy
6Division of Hematology, AZ Osp SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
7Oncologia Medica, Università di Modena e Reggio Emilia, Modena, Italy
8Hematology II, Azienda Ospedaliera Città della Salute, Torino, Italy
9Department of Haematology and Bone Marrow Transplantation, Regional Hospital, S. Maurizio, Bolzano/Bozen, Italy
10Division of Hematology, Ospedale Businco, Cagliari, Italy
11Division of Hematology, IRCCS CRO Aviano, Aviano (PD), Italy
12Division of Hematology, Fondazione IRCCS Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy
13Division of Hematology II, AOU Citta della Salute e della Scienza, Torino, Italy
14Department of Hematology, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy
15Program of Innovative Therapy in Oncology and Hematology, Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Modena, Italy
16Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
17Fondazione Italiana Linfomi Onlus, Alessandria, Italy
18Italian Lymphoma Foundation (FIL), Alessandria, Italy
19Alessandria, Hospital, Alessandria, Italy
20SCDU Epidemiologia dei Tumori-CPO Piemonte, Az Osp Citta della salute e della Scienza, Torino, Italy
21Division of Hematology, Az Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

David Cunningham1*, Pier Luigi Zinzani, MD, PhD2, Sarit E. Assouline, MD MSc3, Krimo Bouabdallah, MD4*, Dominique Bron, MD, PhD5, Corinne Haioun, MD, PhD6, Luigina Mollica, MD, FRCPC, PhD7, Marius Giurescu, MD, PhD8*, Igor Gorbatchevsky, MD9, Manoel Neves, MD10*, Marta M. Lemos, MD10, Julia Grunert, PhD11*, Florian Hiemeyer, PhD8*, Barrett H. Childs, MD12 and Martin H. Dreyling, MD, PhD13

1The Royal Marsden Hospital, London and Surrey, United Kingdom
2Institute of Hematology “L. & A. Seràgnoli”, University of Bologna, Bologna, Italy
3Jewish General Hospital, Montreal, QC, Canada
4CHU de Bordeaux, Bordeaux, France
5Hematology, Institut Jules Bordet, ULB, Brussels, Belgium
6Lymphoid Malignancies Unit, AP-HP, Groupe Hospitalier Mondor, Créteil, France
7Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
8Bayer Pharma AG, Berlin, Germany
9Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ
10Bayer HealthCare, Sao Paulo, Brazil
11Bayer Pharma AG, Wuppertal, Germany
12Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, NJ
13Dept. of Medicine III, Univ. Hospital Grosshadern/LMU, Munich, Germany

Huiqiang Huang, MD1,2, Yan Gao3*, XiaoXiao Wang3*, Qingqing Cai, MD1*, QiChun Cai4*, Bing Bai5*, Zheng Yan5*, Wenqi Jiang6*, Zhongjun Xia, MD7 and ZhiMing Li3*

1Department of Medical Oncology, Cancer Center of Sun Yat-sen University,State Key Laboratory of Oncology in Southern China, Guangzhou, China
2State Key Laboratory of Oncology in South China, Guangzhou, China
3Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
4Department of Medical Oncology, Guangdong General Hospital,Guangdong Academy of Medical Sciences, Guangzhou, China
5Sun Yat-Sen University Cancer Center, Guangzhou, China
6Department of Medical Oncology, Cancer Center of Sun Yat-sen University, Guangzhou, China
7Dept. of Medical Oncology, Cancer Center of SUMS, Guangzhou, China

Cinzia Pellegrini1*, Alessandro Broccoli, MD1*, Beatrice Casadei1*, Annalisa Chiappella, MD2, Paolo Corradini, MD3, Enrico Derenzini, MD4*, Anna Dodero, MD5*, Lucia Farina, MD, PhD3*, Letizia Gandolfi1*, Marco Ladetto6, Federico Monaco6*, Lorella Orsucci, MD7*, Federica Quirini1*, Flavia Salvi, MD6*, Francesco Spina, MD3*, Vittorio Stefoni1*, Lorenzo Tonialini1*, Umberto Vitolo, MD8, Lisa Argnani1* and Pier Luigi Zinzani, MD, PhD9

1Institute of Hematology, University of Bologna, Bologna, Italy
2Department of Hematology, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy
3Division of Hematology, IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy
4DIMES, Department of Hematology and Medical Sciences “L. and A. Seràgnoli”, University of Bologna, Bologna, Italy
5Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
6Hematology, “SS Antonio e Biagio” Hospital, Alessandria, Italy
7Division of Hematology, A.O.U. Citta della Salute e della Scienza di Torino, Torino, Italy
8SC Ematologia Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy
9Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy

Luca Arcaini1*, Caroline Besson2, Jan Peveling-Oberhag, MD3*, Véronique Loustaud-Ratti, MD, PhD4*, Sara Rattotti1*, Virginia Ferretti, PhD1*, Anna Linda Zignego, MD, PhD5*, Milvia Casato, MD, PhD6*, Michele Merli, MD7*, Olivier Hermine8* and Carlo Visco, MD9*

1Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
2APHP CHU Bicêtre, University of Paris Sud, INSERM U1012, Le Kremlin Bicêtre, France
3Department of Internal Medicine 1, Goethe-University Hospital, Frankfurt, Germany
4U850 INSERM, University of Limoges, Limoges, France
5Interdepartmental Center MaSVE, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
6Division of Clinical Immunology, Sapienza University, Roma, Italy
7Division of Hematology, Ospedale di Circolo and Fondazione Macchi, Varese, Italy
8Department of Hematology, Necker Children's hospital, APHP, Paris, France
9Department of Hematology and Cell Therapy, Ospedale San Bortolo, Vicenza, Italy

Kristina Drott, MD, PhD1*, Hans Hagberg, MD, PhD2*, Thomas Relander, MD, PhD1*, Cecilia Graffman, MD, PhD1*, Johan Drott, PhD3* and Mats Jerkeman, MD, PhD4

1Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden
2Immunology, Genetics and Pathology, Uppsala university, Uppsala, Sweden
3Respiratorius AB, Lund, Sweden
4Department of Oncology, Skåne University Hospital, Lund University, Lund, Sweden

Hiromichi Takahashi, MD, PhD1,2*, Sumiko Kobayashi, MD, PhD1, Katsuhiro Miura, MD1*, Daisuke Kurita, MD1*, Yoshihiro Hatta, MD, PhD1, Masahiko Sugitani, MD, PhD3*, Shimon Otake, MD1*, Masaru Nakagawa, MD, PhD1*, Masashi Sakagami, MD1*, Yoshihito Uchino, MD1*, Hitomi Kodaira, MD1*, Noriyoshi Iriyama, MD, PhD1*, Machiko Kusuda, MD1*, Atsuko Hojo1*, Mai Yagi, MD1*, Yukio Hirabayashi, MD, PhD1*, Yujin Kobayashi, MD, PhD1*, Tomohiro Nakayama, MD, PhD2* and Masami Takei, MD, PhD1*

1Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan
2Division of Laboratory Medicine, Department of Pathology of Microbiology, Nihon University School of Medicine, Tokyo, Japan
3Department of Pathology, Nihon University School of Medicine, Tokyo, Japan

Stefanie Kreissl, MD1*, Helen Goergen2*, Bastian von Tresckow, MD1*, Karolin Behringer, MD1*, Jana Markova, MD3*, Andreas Lohri, MD4, Julia Meissner, MD5*, Josée M Zijlstra, MD, PhD6*, Richard Greil, MD7*, Max S. Topp, MD8, Martin Sökler, MD9*, Hartmut Döhner, MD10, Volker Diehl, MD2, Andreas Engert, MD1 and Peter Borchmann, MD1

1Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany
2German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany
3Department of Hematology, Third Faculty of Medicine, Charles University in Prague, University Hospital Kralovske Vinohrady, Prague, Czech Republic
4Department of Oncology and Hematology, Cantonal Hospital, Liestal, Switzerland
5Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany
6Department of Hematology, VU University Medical Center Amsterdam, Amsterdam, Netherlands
7Department III for Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg; Salzburg Cancer Research Institute and AGMT, Salzburg, Austria
8Department of Internal Medicine II, Division of Hematology and Medical Oncology, Wuerzburg University Medical Center, Wuerzburg, Germany
9Department II of Internal Medicine, University Hospital, Tübingen, Germany
10Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany

Dok Hyun Yoon, MD, PhD1*, Seok Jin Kim, MD, PhD2, Seong Hyun Jeong, MD3*, Dong-Yeop Shin, MD,4*, Sung Hwa Bae, M.D.5, Junshik Hong, M.D.6, Seong Kyu Park, MD7*, Ho-Young Yhim, MD8, Deok-Hwan Yang, MD9, Hye Won Lee, MD10*, Mark Lee, MD, PhD11, Hyeonseok Eom, M.D., Ph.D12, Jae-Yong Kwak, MD, PhD13, Jae Hoon Lee6, Cheolwon Suh14 and Won Seog Kim, MD, PhD15*

1Department of Oncology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
2Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
3Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, South Korea
4Korea Cancer Center Hospital, Seoul, South Korea
5Internal Medicine, Daegu Catholic University Hospital, Daegu, South Korea
6Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea
7Hematology/Oncology, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea
8Department of Internal Medicine, Chonbuk National University School of Medicine, Jeonju, South Korea
9Department of Internal Medicine, Chonnam National University Medical School, Gwangju, South Korea
10National Cancer Center, Ilsan, South Korea
11hematology/Oncology, Konkuk University Medical Center, Seoul, South Korea
12National Cancer Ctenter, Goyang-Si, South Korea
13Department of Internal medicine, Chonbuk National University Medical School & Hospital, Jeonju, South Korea
14Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
15Samsung Medical Center, Seoul, South Korea

Jan M Zaucha, MD, PhD1,2, Bogdan Malkowski, MD3*, Edyta Subocz, MD4*, Stephane Chauvie, PhD5*, Joanna Tajer, MD6*, Waldemar Kulikowski, MD7*, Agnieszka Fijolek-Warszewska, MD8*, Alberto Biggi, MD9*, Federico Fallanca, MD10*, Malgorzata Kobylecka, MD11*, Miroslaw Dziuk, MD, PhD8,12*, Dariusz Woszczyk, MD13*, Justyna Rybka, MD14*, Renata Kroll-Balcerzak, MD15*, Fabrizio Bergesio, PhD5*, Agnieszka Romanowicz, MD16*, Agnieszka Chamier-Cieminska, MD17*, Pawel Kurczab, MD18*, Agnieszka Giza19*, Krzysztof Lesniewski-Kmak, MD1,2*, Wanda Knopinska-Posluszny, MD, PhD20*, Jan Walewski, MD PhD Prof21 and Andrea Gallamini, MD22

1Department of Radiotherapy and Clinical Oncology, Gdynia Oncology Center, Gdynia, Poland
2Department of Oncological Propedeutics, Medical University of Gdansk, Gdansk, Poland
3Nuclear Medicine Department, Oncology Center in Bydgoszcz, Bydgoszcz, Poland
4Department of Hematology, Military Institute of Medicine, Warszawa, Poland
5Medical Physics Department, Ospedaliera S. Croce e Carle Santa, Cuneo, Italy
6Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie Memorial Institute, Warszawa, Poland
7Clinical Department of Hematology, Interior Ministry Hospital, Warmia and Mazury Medical University, Olsztyn, Poland
8Affidea Mazovian PET/CT Center, Warszawa, Poland
9Nuclear Medicine Department, Ospedaliera S. Croce e Carle Santa, Cuneo, Italy
10Nuclear Medicine Department, San Raffaele Research Institute, Milano, Italy
11Nuclear Medicine Department, Warsaw Medical University, Warszawa, Poland
12Nuclear Medicine Department, Military Institute of Medicine, Warszawa, Poland
13Department of Hematology, Provincial Hospital, Opole, Poland
14Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
15Department of Hematology, University Medical School, Poznan, Poland
16Department of Oncology and Hematology, Central Clinical Hospital MSW, Warszawa, Poland
17Department of Clinical Oncology, Oncology Center in Bydgoszcz, Bydgoszcz, Poland
18Medical Center Mrukmed with Outpatient Chemotherapy Unit, Rzeszów, Poland
19Department of Hematology, Jagiellonian University Medical College, Krakow, Poland
20Clinical Hematology Department, Interior Ministry Hospital, Warmia and Mazury Medical University, Olsztyn, Poland
21Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
22Research, Innovation & statistics department., A. Lacassagne Cancer Center,, Nice, France

Sara Alonso*, MD1*, Miguel Alcoceba*, MD2*, Laura Magnano, MD3*, Marcio Andrade, MD4*, María García-Álvarez, BsC5*, Santiago Mercadal, MD6*, Guillermo Rodríguez, MD7*, Olga Garcia, MD8*, Juan-Manuel Sancho9*, Antonio Salar, MD, PhD10*, Francesc Pasarolls, MD10*, Maria Jose Terol, MD, PhD11*, Carlos Grande, MD12*, Sonia González de Villambrosia, MD13*, Raul Cordoba, MD14*, Silvana Novelli, MD15*, Lourdes López, MD16*, Carlos Montalbán, MD PhD17*, Erik de Cabo, MD18*, Mari­a Stefania Infante, MD19*, Emilia Pardal, MD, PhD20*, Javier Lopez-Jimenez, MD21*, Beatriz Antelo, MD22*, Reyes Arranz, MD23*, Marcos González, MD, PhD2*, Alejandro Martín24*, Armando López-Guillermo‡25 and Maria Dolores Caballero‡26*

1Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
2Hospital Clínico Universitario de Salamanca, Salamanca, Spain
3Hospital Clinic,IDIPAS, Barcelona, Spain
4Department of Hematology, Hospital Universitario Miguel Servet, Zaragoza, Spain
5Hematology Department, University Hospital of Salamanca, Salamanca, Spain
6Institut Català d’Oncologia, Hospital Duran i Reynals, Barcelona, Spain
7Hospital Virgen del Rocío, Sevilla, Spain
8Department of Hematology, ICO Badalona-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute. Universitat Autònoma de Barcelona, Badalona, Spain
9ICO-Germans Trias i Pujol Hospital., Badalona, Spain
10Hospital del Mar, Barcelona, Spain
11Dept. of Hematology/Oncology, Hospital Clinico Universitario, Valencia, Spain
12Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
13Hospital Universitario Marqués de Valdecilla, Santander, Spain
14Fundación Jiménez Díaz, Madrid, Spain
15Hospital Universitario Sant Pau, Barcelona, Spain
16Translational Research, MD Anderson Cancer Center, Madrid, Madrid, Spain
17Hematology, MD Anderson Cancer Center Madrid, Madrid, Spain
18Department of Hematology, Hospital del Bierzo, Ponferrada (León), Spain
19HOSPITAL INFANTA LEONOR, Madrid, Spain
20Virgen del Puerto University, Plasencia, Spain
21Hospital Universitario Ramón y Cajal, Madrid, Spain
22Hospital de Nuestra Señora de la Esperanza, Santiago de Compostela, Spain
23Hospital Universitario La Princesa, Madrid, Spain
24Department of Hematology / IBSAL, Hospital Universitario de Salamanca, Salamanca, Spain
25Hematologia, Hospital Clínic, Barcelona, Spain
26University Hospital of Salamanca, Salamanca, Spain

Rong Liang, PhD MD1*, Gao Guangxun, PhD MD1*, Chen Jie Ping, PhD MD2*, Jishi Wang3, Xiao min Wang, PhD MD4*, Yun Zeng, PhD MD5*, Xie qun Chen, PhD MD6* and Liang Zhang, MD, PhD7

1hematology, Xijing Hospital, Fourth Military Medical Unversity, Xi'an, China
2hematology, Xinan hospital, Third Military Medical University, Chongqing, China
3Department of Hematology, Affiliated Hospital of Guiyang Medical College, Guiyang, China
4hematology, Xinjiang autonomous region hospital;, Wulumuqi, China
5PhD MD, The Affiliated Hospital of Kunming Medical University;, Kunming, China
6hematology, Xijing Hospital, Fourth Military Medical Unversity, xi'an, China
7Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Vittorio Stefoni1*, Cinzia Pellegrini1*, Letizia Gandolfi1*, Luca Baldini2*, Monica Tani3*, Emanuele Cencini4*, Amalia Figuera5*, Michela Ansuinelli6*, Elisa Bernocco7*, Maria Cantonetti8*, M. Christina Cox, MD9*, Filippo Ballerini, MD10*, Chiara Rusconi, MD11*, Carlo Visco, MD12*, Luca Arcaini13*, Angela Fama14*, Roberto Marasca15, Francesco Zaja16, Alessia Castellino17*, Catello Califano18*, Marina Cavaliere19*, Guido Gini, MD20*, Anna Marina Liberati21, Gerardo Musuraca, M.D.22*, Anna Lucania23*, Giuseppina Ricciuti24*, Lisa Argnani1* and Pier Luigi Zinzani, MD, PhD25

1Institute of Hematology, University of Bologna, Bologna, Italy
2Division of Hematology, Fondazione IRCCS Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy
3Unit of Hematology, Santa Maria delle Croci Hospital, Ravenna, Italy
4Hematology Unit, Ospedale Santa Maria alle Scotte and University of Siena, Siena, Italy
5Division of Haematology, AOU Policlinico-Vittorio Emanuele, Catania, Italy
6Haematology, Department of Cellular Biotechnologies and Hematology, 'Sapienza' University, Rome, Italy
7Division of Haematology - SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandrio, Italy
8UOC Oncohaematology Policlinico Tor Vergata, Rome, Italy
9Hematology, Sant'Andrea Hospital, La Sapienza University, Rome, Italy
10Chair of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy
11Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
12Department of Hematology and Cell Therapy, Ospedale San Bortolo, Vicenza, Italy
13Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
14Hematology-Arcispedale S.Maria Nuova IRCCS, Reggio Emilia, Italy
15Dept of Medical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Modena, Italy
16Chair of Hematology, DRMM, University of Udine, Udine, Italy
17A.O. Città della Salute e della Scienza di Torino, Torino, Italy
18Onco-Ematologica Ospedale Pagani, Salerno, Italy
19Medicine I and Haematology, San Paolo Hospital, Savona, Italy
20Affiliate Clinic of Hematology- Ospedali Riuniti, Ancona, Italy
21S.C. Oncoematologia, A.O. S. Maria di Terni, Terni, Italy
22Onco-hematology, IRST, Meldola, Italy
23Haematology Unit, ASL Napoli 1 Centro, Naples, Italy
24Department of Hematology, Lymphoma Unit, Spirito Santo Hospital, Pescara, Italy
25Institute of Hematology “L. & A. Seràgnoli”, University of Bologna, Bologna, Italy

Anthony Q Pham, MD1, Stephen Broski2*, Thomas M. Habermann, MD3, Dragan Jevremovic, MD PhD4*, Gregory Wiseman, MD1*, Andrew L Feldman, MD1, Matthew J Maurer, MS5, Kay Ristow1* and Thomas E. Witzig, MD6

1Mayo Clinic, Rochester, MN
2Diagnostic Radiology, Mayo Clinic, Rochester, MN
3Hematology, Mayo Clinic Rochester, Rochester, MN
4Hematopathology and Metabolic Hematology Laboratory, Mayo Clinic, Rochester, MN
5Department of Health Sciences Research, Mayo Clinic, Rochester, MN
6Division of Hematology, Mayo Clinic, Rochester, MN

Anjana Joel, MD1*, Prasanth Ganesan, MD, DM1*, Tenali Gnana Sagar, MD, DM1*, Krishnarathnam Kannan, MD, DM2*, Trivadi Ganesan, MD1*, Venkatraman Radhakrishnan, MD, DM1*, Rejiv Rajendranath, MD, DM1*, Shirley Sundersingh, MD3* and Vandana Vikas, MD4*

1Department of Medical Oncology, Cancer Institute(WIA), Chennai, India
2Department of Medical Oncology, Cancer Institute (WIA), Chennai, India
3Department of Pathology, Cancer Institute(WIA), Chennai, India
4Department of Radiology, Cancer Institute(WIA), Chennai, India

Angelo Fama, MD1*, Patrizia Ciammella, MD2*, Massimiliano Casali, MD3*, Elisa Barbolini, PhD4*, Ala Podgornii, MD5*, Mauro Iori, PhD6*, Annibale Versari, MD7*, Franceso Merli, MD1* and Giacomo Feliciani, MD6*

1Hematology Unit, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy
22 Radiation Oncology Unit, Department of Advanced Technology, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy
3Department of Nuclear Medicine, Arcispedale S. Maria Nuova - Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy
4Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Hematology, Reggio Emilia, Italy
5Radiation Oncology Unit, Department of Advanced Technology,, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, reggio emilia, Italy
6Medical Physics Unit, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy
7Santa Maria Nuova Hospital, Reggio Emilia, Italy

Roopesh R. Kansara, MD1, Joseph M. Connors, MD2, Kerry J. Savage, MD MSc2,3, David W Scott, MBChB, PhD3, Randy D. Gascoyne4, Alina S Gerrie, MD2, Laurie H. Sehn2 and Diego Villa, MD, MPH5

1Centre for Lymphoid Cancer and Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
2British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
3Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
4British Columbia Cancer Agency, Centre for Lymphoid Cancer, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
5BC Cancer Agency and University of British Columbia, Centre for Lymphoid Cancer, Vancouver, BC, Canada

Juliette Bouteloup, MD1*, Salim Kanoun, MD2*, Alina Berriolo-Riedinger, MD3*, Hervé Ghesquières, MD4*, Gilles A. Salles, MD, PhD5, Thérèse Gargi6*, Thomas Mognetti, MD7*, Emmanuelle Nicolas-Virelizier, MD6*, Amine Belhabri, MD6*, Rey Philippe, MD6*, Laurent Voillat, MD8*, Cedric Rossi, MD9*, Robin Noël, MD10*, Jean-Noel M. Bastie, MD, PhD11 and Olivier Casasnovas, MD12*

1Department of Haematology, hospital, Chalon sur Saône, France
2Nuclear Medicine Department, Centre Georges Francois Leclerc, dijon, France
3Nuclear Medicine Department, Centre G.F. Leclerc, Dijon, France
4Department of Haematology, centre Leon Berard, lyon, France
5Hospices Civils de Lyon, University Claude Bernard, Pierre-Benite, France
6Centre Leon Berard, Lyon, France
7Centre Leon Berard, lyon, France
8Hospital, Chalon sur saone, France
9CHU, Dijon, France
10hospital, Toulon, France
11CHU Dijon Bocage, Dijon, France
12Hematology Department, Hopital Le Bocage, CHU Dijon, Dijon, France

Tatyana Feldman, MD1, Michael McGuire, PharmD2*, Claudio Faria, PharmD, MPH2*, Andre Goy, MD1, Charles Michael Farber3, Kelly Choi, MD4*, Jacqueline Connors, RN OCN4*, Dhakshila Paramanathan4*, Eric Schultz4* and Stuart L. Goldberg, MD1,4

1John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
2Celgene, Summit, NJ
3Morristown Medical Hospital, Carol G. Simon Cancer Center, Morristown, NJ
4COTA, New York, NY

Eun-Ji Choi, MD1*, Dok Hyun Yoon, MD, PhD2*, Chan-Sik Park3*, Jooryung Huh3*, Sang-wook Lee4*, Eun Jin Chae5*, Jin-Sook Ryu6* and Cheolwon Suh7

1Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
2Department of Oncology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
3Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
4Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
5Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
6Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
7Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Neta Goldschmidt, MD,1*, Ora B. Paltiel, MDCM, MSc2, Dina Ben Yehuda3*, Geffen Kleinstern4*, Alexander Gural, MD5*, Diana Libster, MD6, David Lavie, MD7* and Moshe E. Gatt, MD8

1Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
2Hadassah Medical Center & Hebrew University School of Public Health, Jerusalem, Israel
3Hematology Division, Hadassah Medical Center, Jerusalem, Israel
4School of Public Health, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
5hematology, Hadassah Medical Center, Jerusalem, Israel
6Hematology Mt. Scopus, Hebrew University-Hadassah Medical Organization, Jerusalem, Israel
7Department of Hematology and Bone Marrow Transplantation, Hebrew University-Hadassah Medical Organization, Jerusalem, Israel
8Hadassah Hebrew University Medical Center, Jerusalem, Israel

Carlos Montalbán, MD PhD1*, Antonio Díaz-López, PhD2*, Heidys Garrote Santana, MD2*, Julián Matias Freue, MD2*, Lourdes López, MD2*, Raquel De Oña, MD1*, Ana M Martín Moreno, PhD2*, Armando López-Guillermo3, Ivan Dlouhi3*, Jordina Rovira3*, Mario Rodríguez4*, José Maria Sánchez Pina4*, Sara Alonso, MD5*, Alejandro Martín García, MD PhD6*, Silvana Novelli, MD7*, Juan-Manuel Sancho8*, Olga García8*, Antonio Salar, MD, PhD9*, Antonio Gutierrez, MD, PhD10, Mariana Bastos11*, Maria Rodriguez-Salazar, MD, PhD12*, Ruben Fernández13*, Juan F. Domínguez14*, Jose A. Queizán15*, Sonia González de Villambrosia16*, Raúl Córdoba17*, Victor Abraira18*, Jose Rodríguez, MD1* and Juan F. Garcia, MD PhD2,19*

1Hematology, MD Anderson Cancer Center Madrid, Madrid, Spain
2Translational Research, MD Anderson Cancer Center, Madrid, Madrid, Spain
3Hematology, Hospital Clinic, Barcelona, Spain
4Hematology, 12 de Octubre Hospital, Madrid, Spain
5Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
6Hematology, Salamanca Hospital, Salamanca, Spain
7Hospital Universitario Sant Pau, Barcelona, Spain
8Servicio de Hematologia, Hospital Germans Trias i Pujol, Badalona, Spain
9Hospital del Mar, Barcelona, Spain
10Hematology, Hospital Son Espases, Palma de Mallorca, Spain
11Hematology, Gregorio Marañon Hospital, Madrid, Spain
12Canary Islands Universitiy Hospital, Santa Cruz de Tenerife, Spain
13Hematology, Cabueñes Hospital, Gijón, Spain
14Hematology, Virgen del Rocio Hospital, Seville, Spain
15Hematology, Segovia Hospital, Segovia, Spain
16Marques de Valdecilla Hospital, Santander, Spain
17Fundación Jiménez-Díaz Hospital, Madrid, Spain
18Ramon y Cajal Hospital Fundation, Madrid, Spain
19Pathology, MD Anderson Cancer Center Madrid, Madrid, Spain

Tongyu Lin1*, Xueying Li1*, Tingzhi Liu2*, He Huang1*, Huangming Hong1*, Chengcheng Guo1*, Xiaohong Fu1*, Xiaojie Fang1*, Zhao Wang1*, Zhongjun Xia, MD1,3 and Xiaoting Lin1*

1Sun Yat-sen University Cancer Center, Guangzhou, China
2The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
3Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

Vérène Dougoud-Chauvin, MD1*, Michael G Fradley, MD1,2*, Lu Chen1,2*, Jongphil Kim1,2*, Christine M Walko, PharmD, BCOP1,2*, Marina Sehovic1,2* and Martine Extermann, MD, PhD3,4

1Moffitt Cancer Center, Tampa, FL
2University of South Florida, Tampa, FL
3Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Oncology Sciences, University of South Florida, Tampa, FL

Alessandra Tedeschi, MD1*, Paola Picardi, MD1*, Maria Cecilia Goldaniga, MD2*, Gloria Margiotta Casaluci, MD3*, Giulia Benevolo, MD4*, Simone Ferrero, MD5*, Marzia Varettoni, MD6*, Claudia Baratè, MD7*, Guido Gini, MD8, Carlo Visco, MD9*, Marina Motta, MD10, Valeria Belsito Petrizzi, MD11*, Francesco Zaja, MD12, Erica Ravelli, MD13*, Massimo Gentile, MD14*, Anna Maria Frustaci, MD1*, Lorella Orsucci, MD4*, Enrica Morra, MD1, Gianluca Gaidano3* and Roberto Cairoli, MD1*

1Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
2UO Ematologia e Centro Trapianti di Midollo, IRCCS Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milano, Italy
3Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
4Division of Hematology, A.O.U. Citta della Salute e della Scienza di Torino, Torino, Italy
5Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
6Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
7Università degli Studi - Ospedale Santa Chiara, Department of Clinical and Experimental Medicine, Section of Hematology, Pisa, Italy
8Hematology Department, Ospedali Riuniti di Ancona, Ancona, Italy
9Department of Hematology and Cell Therapy, Ospedale San Bortolo, Vicenza, Italy
10Department of Hematology, Spedali Civili di Brescia Hospital, Brescia, Brescia, Italy
11Medicina Interna ed Onco-Ematologia, Presidio Ospedaliero Umberto I, Nocera Inferiore, Italy
12Centro Trapianti e Terapie Cellulari “Carlo Melzi” DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy
13U.O.C Medicina Interna ed Ematologia, Ospedale Valduce, Como, Italy
14Dipartimento di Oncoematologia, Ospedale Annunziata di Cosenza, Cosenza, Italy

Carole Lacout1*, Manon De Vries1*, Valérie Seegers-Thepot1*, Aline Clavert, MD2*, Jonathan Farhi1*, Mélanie Mercier, MD2*, Marie-Pierre Moles2*, Norbert Ifrah, MD, PhD3, Mathilde Hunault2* and Aline Tanguy-Schmidt, MD4*

1CHU, Angers, France
2Hematology, CHU, Angers, France
3Hematology Department, University Hospital, Angers, France
4University Hospital of Angers, Angers, France

Grommes Christian, MD1*, Kaley Thomas, MD2*, Omar Abdel-Wahab2, Antonio M. Omuro, MD1*, Mellinghoff Ingo2* and Lisa DeAngelis, MD3*

1Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Neurology, Memorial Sloan Kettering, New York, NY

Peter Martin, MD1, Zhengming Chen, PhD2*, Bruce D. Cheson, MD3, Tricia Ellis4*, Katherine Sue Robinson, MD, FRCPC5, Michael E. Williams, MD6, Saurabh A. Rajguru, MD7*, Jonathan W. Friedberg, MD, MMSc8, Richard H. van der Jagt9, Ann S. LaCasce, MD10, Robin Joyce, MD11, Kristen N. Ganjoo, MD12*, Nancy L Bartlett, MD13, Bernard Lemieux, MD, FRCP14, Ari M. Vander Walde, M.D., M.P.H.15, Jordan A. Herst, MD, FRCPC16, Jeffrey Szer, MB BS FRACP17, Michael H. Bar, MD18, Fernando Cabanillas, MD19, Anthony J. Dodds, FRACP, FRCPA20, Paul G. Montgomery, MD21, Bryn Pressnail22*, Mitchell R. Smith, MD, PhD23 and John P. Leonard, MD24

1Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY
2Department of Public Health, Weill Cornell Medical College, New York, NY
3Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
4Weill Cornell Medical College, New York, NY
5QEIIHSC, Victoria General Hosp. Site, Dalhousie University, Halifax, NS, Canada
6Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA
7University of Wisconsin Hospital & Clinics, Madison, WI
8University of Rochester, Rochester, NY
9Ottawa Hospital-General Campus, Ottawa, ON, Canada
10Dana-Farber Cancer Institute, Boston, MA
11Division of Hematology and Oncology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA
12Palo Alto VAHCS, Stanford University, Palo Alto, CA
13Washington University School of Medicine, Saint Louis, MO
14Hemato-oncology department, CHUM, Montreal, QC, Canada
15Hematology and Stem Cell Transplantation, City of Hope, Duarte, CA
16Sudbury Regional Hospital, Sudbury, ON, Canada
17Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia
18Bennett Cancer Ctr., Stamford, CT
19Auxilio Cancer Center, Hospital Auxilio Mutuo, San Juan, PR
20St. Vincent's Hospital, Sydney, Australia
21Mountain States Tumor Institute, Boise, ID
22Royal Victoria Hospital, Barrie, ON, Canada
23Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
24Department of Medicine, Weill Cornell Medical College, New York, NY

Anne Parcelier, MD1*, Pierre Morel, MD1*, Bruno Royer, MD1*, Caroline Delette1*, Isabelle Leduc, MD2*, Henri Sevestre, PhD3* and Jean-Pierre Marolleau1

1Hematology, Centre Hospitalier Universitaire, Amiens, France
2Centre hospitalier, Abbeville, France
3Histopathology, Centre Hospitalier Universitaire, Amiens, France

Liat Vidal, MD MSc1*, Liat Shargian, MD2,3*, Ofer Shpilberg, MD, MPH4,5*, Ron Ram, MD6,7, Pia Raanani, MD8,9, Ronit Gurion, MD1* and Anat Gafter, MD1*

1Davidoff Cancer Center, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva, Israel
2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
3Institute of Hematology, Davidoff Cancer Centere, Beilinson Hospital, Rabin Medical Centere, Petah-Tiqva, Israel
4Sackler School of Medicine, Tel Aviv University, Tel - Aviv, Israel
5Assuta Medical Centers, Tel-Aviv, Israel
6BMT Unit, Tel Aviv Medical Center, Tel Aviv, Israel
7Tel Aviv University, Tel Aviv, Israel
8Institute of Hematology, Davidoff cancer center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel, Petah Tikva, Israel
9Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Nicola Lehners, MD1*, Isabelle Kraemer, MD1*, Ronald Koschny, MD2*, Gerlinde Egerer, MD1*, Anthony D. Ho, MD1 and Mathias Witzens-Harig, MD3*

1Dept. Med. V, University Hospital Heidelberg, Heidelberg, Germany
2Dept. Med. IV, University Hospital Heidelberg, Heidelberg, Germany
3Dep. Med. V, University Hospital Heidelberg, Heidelberg, Germany

Mohamed Amin Ahmed, MD1*, Yasuhiro Oki, MD1, Mansoor Noorani1*, Loretta Nastoupil, MD2, Luis E. Fayad, MD1, Fredrick B. Hagemeister, MD1, Alma Rodriguez, M.D.1*, Richard Eric Davis, M.D.1* and Jason R Westin, MD1

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2University of Texas MD Anderson Cancer Center, Houston, TX

Kevin R. Kelly, MD, PhD1, Nashat Y. Gabrail, MD2*, William J Edenfield, MD3*, A Craig Lockhart4*, Anthony J. Olszanski, MD, PhD5* and Guru Reddy6*

1University of Southern California Keck School of Medicine, Los Angeles, CA
2Gabrail Cancer Center, Canton, OH
3Cancer Centers Of The Carolinas, Greenville, SC
4Washington University School of Medicine, St Louis
5Dartmouth-Hitchcock Medical Center Norris Cotton Cancer Center, Lebanon, NH
6spectrum pharmaceuticals, irvine

Reinhard Marks1, Tim Strüssmann2*, Alexander Baumgarten2* and Jürgen Finke, M.D.2

1Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany
2University Medical Center Freiburg, Freiburg, Germany

Sabarish Ayyappan, MD1*, Dhivya Prabhakar, MD2*, Vinita Gupta, MD3, Brenda Cooper, MD3, Hillard M. Lazarus, MD3, Marcos De Lima, MD3 and Paolo F. Caimi, MD3

1University Hospitals Case Medical Center, Cleveland, OH
2Department of Medicine, University Hospitals Case Medical Center, Cleveland, OH
3Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH

*signifies non-member of ASH